Blog
RSS FeedPosted by Michael Wonder on 13 Feb 2017
Outcomes from the November 2016 PTAC meeting
13 February 2017 - PHARMAC has published the minutes from the 3-4 November meeting. ...
Posted by Michael Wonder on 13 Feb 2017
NICE approves Incyte’s leukaemia drug for routine NHS use
13 February 2017 - NICE published draft guidance recommending ponatinib (Iclusig) for routine use on the NHS, to treat some ...
Posted by Michael Wonder on 12 Feb 2017
Agenda for 22 February 2017 TC meeting
10 February 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 11 Feb 2017
Health Minister Greg Hunt steps in to ensure Meningococcal B vaccine supply
11 February 2017 - Australian kids will regain full access to a lifesaving meningococcal vaccination within weeks after Health Minister ...
Posted by Michael Wonder on 11 Feb 2017
Cancer drugs may be delayed after Brexit, say experts
10 February 2017 - Patients in the UK could face delays getting new drugs if Britain withdraws from the EU's ...
Posted by Michael Wonder on 11 Feb 2017
Prostheses list: insurers and health care majors square off
11 February 2017 - The fiery battle between private health insurers and medical device companies has kicked up a gear ...
Posted by Michael Wonder on 11 Feb 2017
‘Cost shifting’ by public hospitals blamed for pushing up the cost of private health insurance
11 February 2017 - You show up at the emergency room injured, vulnerable and in distress. ...
Posted by Michael Wonder on 10 Feb 2017
Decision to maintain full subsidy for gefitinib (Iressa) from 1 April 2017
10 February 2017 - PHARMAC is pleased to announce the approval of a proposal to maintain full subsidy for gefitinib ...
Posted by Michael Wonder on 10 Feb 2017
Lowest health insurance premium increases in a decade
10 February 2017 - The Australian Government’s action to keep the pressure on private health insurers has helped drive the lowest ...
Posted by Michael Wonder on 10 Feb 2017
Post-market review of pulmonary arterial hypertension medicines – public consultation
10 February 2017 - The public submission process is now open for the post-market review of pulmonary arterial hypertension medicines. ...
Posted by Michael Wonder on 09 Feb 2017
Cancer drug prices must come down, say leading research institutes
10 February 2017 - Top UK and US scientists say high cost for medicines is indefensible as they propose cheaper way ...
Posted by Michael Wonder on 09 Feb 2017
Health fund premiums rise $200 a year — how state governments are to blame
9 February 2017 - Health Minister Greg Hunt has approved an average health fund premium rise three times the inflation ...
Posted by Michael Wonder on 09 Feb 2017
Terminal cancer patient priced out of life-prolonging medication
9 February 2017 - The husband of a terminal skin cancer patient says PHARMAC are "tightarses" and life saving medication ...
Posted by Michael Wonder on 08 Feb 2017
Bupa head tackles government for further reductions on costly prostheses
9 February 2017 - Bupa is calling on the Turnbull government to further reform medical device prices as the health ...
Posted by Michael Wonder on 08 Feb 2017
Government to change policy on medicinal cannabis
7 February 2017 - The Government will announce tomorrow that it is removing a significant hurdle to getting access to ...